PURPOSE: Although three or more liver transplantation (LT)s in the same patient arouse not only medical but also ethical issues in the context of organ shortage, it is a fact that additional liver retransplantation (reLT) is the only lifesaving treatment option for those with graft failure after a second LT. However, little is known regarding the risks and benefits associated with a third LT. METHODS: We analyzed fifteen cases of third LT and 48 of second LT performed between January 2000 and December 2010. Clinical outcomes were compared with those of second LT cases performed during the same period. RESULTS: Model for end-stage liver disease (MELD) scores at transplant was similar between the two groups. As for surgical aspects, there was no significant difference in operative time or number of units of red blood cells transfused during the transplant procedures between the groups. Patient and graft survival after the third LT at 1, 3, and 10 years were 66.7, 51.9, and 44.4 %, and 66.7, 51.9, and 29.6 %, respectively. There was no significant difference in patient or graft survival between the groups. However, graft loss within 3 months after the third LT was significantly higher than that of second LT patients. CONCLUSION: Third LT cases showed acceptable short- and long-term outcomes that were not significantly inferior to those of a second LT. Careful patient care especially in the early phase after a third LT may be essential to improve the outcome.
PURPOSE: Although three or more liver transplantation (LT)s in the same patient arouse not only medical but also ethical issues in the context of organ shortage, it is a fact that additional liver retransplantation (reLT) is the only lifesaving treatment option for those with graft failure after a second LT. However, little is known regarding the risks and benefits associated with a third LT. METHODS: We analyzed fifteen cases of third LT and 48 of second LT performed between January 2000 and December 2010. Clinical outcomes were compared with those of second LT cases performed during the same period. RESULTS: Model for end-stage liver disease (MELD) scores at transplant was similar between the two groups. As for surgical aspects, there was no significant difference in operative time or number of units of red blood cells transfused during the transplant procedures between the groups. Patient and graft survival after the third LT at 1, 3, and 10 years were 66.7, 51.9, and 44.4 %, and 66.7, 51.9, and 29.6 %, respectively. There was no significant difference in patient or graft survival between the groups. However, graft loss within 3 months after the third LT was significantly higher than that of second LT patients. CONCLUSION: Third LT cases showed acceptable short- and long-term outcomes that were not significantly inferior to those of a second LT. Careful patient care especially in the early phase after a third LT may be essential to improve the outcome.
Entities:
Keywords:
Donor shortage; Liver retransplantation; Patient survival; Single centre analysis; Third liver transplantation
Authors: J F Markmann; J S Markowitz; H Yersiz; M Morrisey; D G Farmer; D A Farmer; J Goss; R Ghobrial; S V McDiarmid; R Stribling; P Martin; L I Goldstein; P Seu; C Shackleton; R W Busuttil Journal: Ann Surg Date: 1997-10 Impact factor: 12.969
Authors: Carmen Landaverde; Marina Berenguer; Victoria Aguilera; Fernando San Juan; Martín Prieto; Joaquín Berenguer Journal: Med Clin (Barc) Date: 2005-05-21 Impact factor: 1.725
Authors: Edip Akpinar; Gennaro Selvaggi; David Levi; Jang Moon; Seigo Nishida; Eddie Island; Werviston DeFaria; Ernesto Pretto; Philip Ruiz; Andreas G Tzakis Journal: Transplantation Date: 2009-10-15 Impact factor: 4.939
Authors: Hugo R Rosen; Martin Prieto; Teresa Casanovas-Taltavull; Valentin Cuervas-Mons; Olaf Guckelberger; Paolo Muiesan; Russell W Strong; Wolf O Bechstein; John O'grady; Atif Zaman; Benjamin Chan; Joaquin Berenguer; Roger Williams; Nigel Heaton; Peter Neuhaus Journal: Hepatology Date: 2003-08 Impact factor: 17.425
Authors: Renske Postma; Elizabeth B Haagsma; Paul M J G Peeters; Aad P van den Berg; Maarten J H Slooff Journal: Transpl Int Date: 2004-05-29 Impact factor: 3.782
Authors: H R Doyle; F Morelli; J McMichael; C Doria; L Aldrighetti; T E Starzl; I R Marino Journal: Transplantation Date: 1996-05-27 Impact factor: 4.939